Inventor profile of:

Christopher Larson

City:

San Diego, California

Country:

United States

Published Applications:

19

Last publication date:

2025-12-25

Top Assignees for applications by Christopher Larson

The entities that hold a legal rights for patent applications filed by inventor Larson Christopher:

Recent patent applications by Larson Christopher

Christopher Larson from San Diego, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-25
US20250388930A1
Chemistry; metallurgy

TUMOR SELECTIVE TATA-BOX AND CAAT-BOX MUTANTS

#2 | 2025-03-06
US20250074967A1
Chemistry; metallurgy

IMMUNOMODULATORY FUSION PROTEINS

#3 | 2024-09-05
US20240294883A1
Chemistry; metallurgy

A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoter

#4 | 2024-02-15
US20240052016A1
Chemistry; metallurgy

HUMAN IL-10 RECEPTOR ALPHA FUSION PROTEINS

#5 | 2022-04-28
US20220125946A1
Human necessities

Recombinant adenoviruses carrying transgenes

#6 | 2021-05-13
US20210139560A1
Chemistry; metallurgy

Immunomodulatory fusion proteins

#7 | 2021-01-21
US20210015878A1
Human necessities

Personalized cancer vaccines

#8 | 2020-07-16
US20200223901A1
Chemistry; metallurgy

Human IL-10 receptor alpha fusion proteins

#9 | 2020-05-21
US20200155625A1
Human necessities

ANTI-ANGIOGENIC ADENOVIRUS

#10 | 2020-03-12
US20200078415A1
Human necessities

Multiple transgene recombinant adenovirus

#11 | 2020-01-30
US20200032223A1
Chemistry; metallurgy

Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter

#12 | 2019-11-21
US20190352669A1
Chemistry; metallurgy

TUMOR SELECTIVE TATA-BOX AND CAAT-BOX MUTANTS

#13 | 2019-11-21
US20190352616A1
Chemistry; metallurgy

MULTIPLE TRANSGENE RECOMBINANT ADENOVIRUS

#14 | 2018-12-27
US20180369404A1
Human necessities

Recombinant adenoviruses carrying transgenes

#15 | 2018-05-17
US20180134766A1
Chemistry; metallurgy

Immunomodulatory fusion proteins

#16 | 2010-10-28
US20100273797A1
Human necessities

ALPHA-KETOAMIDES AND DERIVATIVES THEREOF

#17 | 2010-04-15
US20100093735A1
Human necessities

Cytokine inhibitors

#18 | 2010-04-15
US20100093734A1
Human necessities

Cytokine inhibitors

#19 | 2005-05-19
US20050107399A1
Human necessities

Alpha-ketoamides and derivatives thereof

InventorID:

2189997 ⎘